MedTrace Logo

King Vision Video Laryngoscope Ambu (aBlade) System for Use in Children

NCT02841189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-06-02

Study results available
· View outcomes & findings →

Summary

This is a single center trial to evaluate the performance of the King Vision video laryngoscope in pediatric patients between the ages of one month and 10 years of age. If the performance is satisfactory, this device may become a standard laryngoscope for tracheal intubation in elective and emergent tracheal intubations.

Conditions

  • Pediatric Anesthesia
  • King Vision Video Laryngoscope Intubation

Interventions

DEVICE

King Vision video Laryngoscope

The King Vision video laryngoscope (Ambu) will be used for tracheal intubation.

Sponsors & Collaborators

  • King Systems Corporation

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Principal Investigators

  • Nicole Horn, MD · Riley Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-11-07
Completion
2017-11-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02841189 on ClinicalTrials.gov